These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27534738)

  • 1. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
    Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
    Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A; Baandrup S; Houtzagers J; Westergren G
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico comparison between metoprolol succinate and bisoprolol on 24-hour systolic blood pressures.
    Jansson SO; Malm AE; Lundström T
    Drugs R D; 2014 Dec; 14(4):325-32. PubMed ID: 25488798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex assessment of efficacy and tolerance of metoprolol CR/ZOK in treating hypertension].
    Podzolkov VI; Strizhakov LA; Pavlov VI; Makolkin VI
    Ter Arkh; 2002; 74(11):74-7. PubMed ID: 12498136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol in the treatment of hypertension in the elderly.
    Broncel M; Chojnowska-Jezierska J; Adamska-Dyniewska H
    J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
    Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.